We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax

News   Sep 26, 2014

 
Emergent BioSolutions Initiates Final Pivotal Study to Support Licensure of BioThrax
 
 
Advertisement
 

RELATED ARTICLES

Unique Melanoma Markers Could Pave the Way for Therapeutic Vaccines

News

Researchers have discovered new markers, known as HLA-associated peptides, that are uniquely present on melanoma tumors. This finding could pave the way for therapeutic vaccines to be developed against melanoma.

READ MORE

Clinical Trial Will Test Inhalation of Two Coronavirus Vaccines Currently in Development

News

Imperial researchers are set to begin trials to assess the safety and effectiveness of two of the UK’s coronavirus vaccines in development, when inhaled into the lungs.

READ MORE

Collaborations Aim to Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

News

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE